Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China

• Main Authors: Pingjin Gao (Author), Kezhi Mei (Author), Hongwei Li (Author), Qiuyan Dai (Author), Xingui Guo (Author), Daifu Zhang (Author), Zhimin Jin (Author), Hua You (Author), Hong Ding (Author), Ke Lü (Author), Shuxian Zhou (Author), Xiaoling Peng (Author), Hui Xu (Author), Pengfei Yin (Author), Licheng Yu (Author), Lin Pi (Author), Qi Hua (Author), Ming Yang (Author), Xiaowei Yu (Author)
• Format: Book
• Published: Elsevier, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Amlodipine (AML) is the initial therapy most commonly prescribed for patients with hypertension in China. However, AML monotherapy is often less effective in achieving blood pressure (BP) control than other agents. Objective: We performed a clinical study to evaluate efficacy and safety...